How much does a box of Ribociclib cost? Are there price differences in different regions or pharmacies?

Ribociclib is a targeted drug used to treat hormone receptor-positive (HR+) HER2-negative breast cancer, usually in combination with tamoxifen or aromatase inhibitors. The original drug Ribociclib has been launched in China and is included in medical insurance. Patients can reduce the burden of treatment through medical insurance reimbursement. There are certain differences in the price of Ribociclib among different regions and pharmacies. The specific price will be affected by various factors such as drug specifications, drug sources, and regional policies.

In China, the original drug of ribociclib has been included in the medical insurance. The common specification is 200mg*63 tablets, and each box sells for about more than 4,000 yuan. Due to inclusion in medical insurance, the actual fees paid by patients may be affected by the reimbursement ratio of medical insurance, so the actual payment amount may vary in different regions. Through medical insurance, patients can usually significantly reduce their out-of-pocket expenses. The specific amount needs to be determined based on the specific policies of the local hospital pharmacy and the patient's medical insurance type.

In Europe, the price of the original drug of ribociclib is relatively high. Common specifications are 21 tablets, 200mg 42 tablets and 200mg*63 tablets. The price of each box may reach more than 20,000 yuan. Prices in Europe are higher, mainly due to factors such as drug pricing policies, production costs, and import tariffs. Therefore, the treatment cost of ribociclib in this region is relatively expensive.

The original drug of ribociclib is also available in the Indian market, and its price is relatively affordable. The price of each box of the original Ribociclib drug in India may be more than 2,000 yuan. Although it is still slightly higher than the domestic price, India's price advantage is more obvious compared to other regions. This price difference is mainly affected by factors such as pricing strategies, production costs, and lower taxes in the Indian pharmaceutical market.

In addition, generic versions of ribociclib have also been launched overseas and have become an economical choice for many patients. For example, the generic version of ribociclib produced by Lucius Pharmaceuticals in Laos has a common specification of 200mg*21 tablets, and each box may be sold for more than 1,000 yuan. Although the ingredients of generic drugs are basically the same as those of brand-name drugs, due to lower production costs, the selling price of generic drugs is significantly lower than that of brand-name drugs, making them an option for some patients seeking to reduce treatment costs.

Reference materials:https://us.kisqali.com/